Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma
Clinical trial NCT00623402 · COMPLETED
Trial details
- NCT number
- NCT00623402
- Sponsor
- University Hospital Schleswig-Holstein
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.